LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 75

Search options

  1. Article ; Online: [No title information]

    Madsen, Morten Brok Molbech / Ivarsen, Anders / Hjortdal, Jesper

    Ugeskrift for laeger

    2023  Volume 185, Issue 48

    Abstract: Corneal grafting is performed approximately 650 times a year in Denmark. A summary of these procedures is given in this review. Fuchs' endothelial dystrophy and pseudophakic bullous keratopathy are frequent indications for transplantation. Previously, ... ...

    Title translation Corneal grafting.
    Abstract Corneal grafting is performed approximately 650 times a year in Denmark. A summary of these procedures is given in this review. Fuchs' endothelial dystrophy and pseudophakic bullous keratopathy are frequent indications for transplantation. Previously, penetrating keratoplasty was the technique of choice but is nowadays mainly used for combined stromal and endothelial pathology. Instead, techniques specifically replacing diseased layers are more common. The Danish Cornea Bank is the only center in Denmark which undertakes preparation and distribution of tissue. The operative procedures are performed at Aarhus University Hospital or Rigshospitalet Glostrup.
    MeSH term(s) Humans ; Corneal Diseases/surgery ; Corneal Diseases/pathology ; Corneal Transplantation ; Cornea ; Fuchs' Endothelial Dystrophy/pathology ; Fuchs' Endothelial Dystrophy/surgery ; Keratoplasty, Penetrating
    Language Danish
    Publishing date 2023-11-27
    Publishing country Denmark
    Document type Review ; English Abstract ; Journal Article
    ZDB-ID 124102-3
    ISSN 1603-6824 ; 0041-5782
    ISSN (online) 1603-6824
    ISSN 0041-5782
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Visual function after ultrathin Descemet's stripping automated endothelial keratoplasty or Descemet's membrane endothelial keratoplasty combined with cataract surgery: a randomised controlled clinical trial.

    Madsen, Morten Brok Molbech / Ivarsen, Anders / Hjortdal, Jesper

    The British journal of ophthalmology

    2023  

    Abstract: Aims: To compare best-corrected visual acuity (BCVA), contrast sensitivity and endothelial cell density (ECD) after ultrathin Descemet's stripping automated endothelial keratoplasty (UT-DSAEK) and Descemet's membrane endothelial keratoplasty (DMEK).: ... ...

    Abstract Aims: To compare best-corrected visual acuity (BCVA), contrast sensitivity and endothelial cell density (ECD) after ultrathin Descemet's stripping automated endothelial keratoplasty (UT-DSAEK) and Descemet's membrane endothelial keratoplasty (DMEK).
    Methods: A randomised, single-blinded, single-centre design was used. 72 patients with Fuchs' endothelial dystrophy and cataract were randomised to UT-DSAEK or DMEK combined with phacoemulsification and lens implantation. 27 patients with cataract were included in a control group and treated with phacoemulsification and lens implantation. The primary outcome was BCVA at 12 months.
    Results: Compared with UT-DSAEK, DMEK resulted in better BCVA with mean differences of 6.1 early treatment diabetic retinopathy study (ETDRS) (p=0.001) after 3 months, 7.4 ETDRS (p<0.001) after 6 months and 5.7 ETDRS (p<0.001) after 12 months. The control group obtained significantly better BCVA with a mean difference of 5.2 ETDRS (p<0.001) compared with DMEK 12 months postoperatively. Compared with UT-DSAEK, contrast sensitivity was significantly better 3 months after DMEK with a mean difference of 0.10 LogCS (p=0.03). However, our study found no effect after 12 months (p=0.08). ECD was significantly lower after UT-DSAEK compared with DMEK with mean differences of 332 cells/mm
    Conclusions: Compared with UT-DSAEK, DMEK resulted in better BCVA 3, 6 and 12 months postoperatively. Twelve months postoperatively, DMEK had a higher ECD than UT-DSAEK; however, no difference in contrast sensitivity was found.
    Trial registration number: NCT04417959.
    Language English
    Publishing date 2023-06-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 80078-8
    ISSN 1468-2079 ; 0007-1161
    ISSN (online) 1468-2079
    ISSN 0007-1161
    DOI 10.1136/bjo-2023-323304
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Macular Thickness After Ultrathin Descemet Stripping Automated Endothelial Keratoplasty and Descemet Membrane Endothelial Keratoplasty Combined With Cataract Surgery: A Randomized Controlled Clinical Trial.

    Molbech Madsen, Morten Brok / Ivarsen, Anders / Hjortdal, Jesper

    Cornea

    2023  Volume 42, Issue 12, Page(s) 1536–1543

    Abstract: Purpose: The aim was to investigate alterations in central retinal thickness (CRT) and their implications for visual acuity after ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) and Descemet membrane endothelial keratoplasty ( ... ...

    Abstract Purpose: The aim was to investigate alterations in central retinal thickness (CRT) and their implications for visual acuity after ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) and Descemet membrane endothelial keratoplasty (DMEK) combined with cataract surgery.
    Methods: A total of 72 eyes of 72 patients with Fuchs endothelial dystrophy and cataract were included and equally randomized to either UT-DSAEK or DMEK. A control group of 40 eyes of 40 patients with cataract were included for cataract surgery. All participants were examined preoperatively as well as 3 and 6 months postoperatively.
    Results: There was no significant difference in CRT between the study groups after surgery ( P = 0.896). A significant difference in best-corrected visual acuity (BCVA) progression over time was found between the study groups ( P < 0.0001). Average improvements of 8.03 EDTRS after UT-DSAEK ( P < 0.001) and 16.77 EDTRS after DMEK ( P < 0.001) were found 6 months postoperatively. No significant correlation was found between the change in BCVA and CRT from baseline to 3 months postoperatively (r 2 < 0.0001, P = 0.96) and from baseline to 6 months postoperatively (r 2 = 0.0053, P = 0.46).
    Conclusions: CRT was not altered by UT-DSAEK, DMEK, or cataract surgery 3 and 6 months postoperatively. BCVA significantly improved 3 and 6 months after UT-DSAEK and DMEK, respectively. No significant correlations were found between the change in BCVA and CRT postoperatively. As such CRT alterations were comparable after UT-DSAEK, DMEK, and cataract surgery.
    MeSH term(s) Humans ; Descemet Membrane/surgery ; Descemet Stripping Endothelial Keratoplasty ; Fuchs' Endothelial Dystrophy/surgery ; Visual Acuity ; Cataract ; Retrospective Studies ; Endothelium, Corneal
    Language English
    Publishing date 2023-02-24
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 604826-2
    ISSN 1536-4798 ; 0277-3740
    ISSN (online) 1536-4798
    ISSN 0277-3740
    DOI 10.1097/ICO.0000000000003256
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Follow-up surveillance of Wilm's tumour - Authors' reply.

    Brok, Jesper / Pritchard-Jones, Kathy / Spreafico, Filippo

    The Lancet. Oncology

    2018  Volume 19, Issue 10, Page(s) e503

    MeSH term(s) Child ; Follow-Up Studies ; Humans ; Kidney Neoplasms ; Neoplasm Recurrence, Local ; Retrospective Studies ; Wilms Tumor
    Language English
    Publishing date 2018-10-01
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2049730-1
    ISSN 1474-5488 ; 1470-2045
    ISSN (online) 1474-5488
    ISSN 1470-2045
    DOI 10.1016/S1470-2045(18)30691-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Maternal versus paternal inheritance of a 132 bp 11p15.5 microdeletion affecting

    Stoltze, Ulrik Kristoffer / Hansen, Thomas Van Overeem / Brok, Jesper Sune / Grønskov, Karen / Tumer, Zeynep / Ahlborn, Lise Barlebo / Schmiegelow, Kjeld / Wadt, Karin A W

    Journal of medical genetics

    2022  Volume 60, Issue 2, Page(s) 128–130

    MeSH term(s) Humans ; Beckwith-Wiedemann Syndrome/genetics ; DNA Methylation ; Genomic Imprinting ; Paternal Inheritance/genetics ; Phenotype ; Maternal Inheritance ; Male ; Female ; RNA, Long Noncoding/genetics
    Chemical Substances KCNQ1OT1 long non-coding RNA, human ; RNA, Long Noncoding
    Language English
    Publishing date 2022-06-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 220881-7
    ISSN 1468-6244 ; 0022-2593
    ISSN (online) 1468-6244
    ISSN 0022-2593
    DOI 10.1136/jmedgenet-2021-108335
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Risk factors for neonatal sepsis in Sub-Saharan Africa: a systematic review with meta-analysis.

    Bech, Christine Manich / Stensgaard, Christina Nadia / Lund, Stine / Holm-Hansen, Charlotte / Brok, Jesper Sune / Nygaard, Ulrikka / Poulsen, Anja

    BMJ open

    2022  Volume 12, Issue 9, Page(s) e054491

    Abstract: Objectives: To identify the risk factors for neonatal sepsis in Sub-Saharan Africa.: Design: Systematic review and meta-analysis.: Data sources: PubMed, Embase, Web of Science, African Index Medicus and ClinicalTrials.gov were searched for ... ...

    Abstract Objectives: To identify the risk factors for neonatal sepsis in Sub-Saharan Africa.
    Design: Systematic review and meta-analysis.
    Data sources: PubMed, Embase, Web of Science, African Index Medicus and ClinicalTrials.gov were searched for observational studies from January 2010 to August 2020.
    Setting: Sub-Saharan Africa, at all levels of healthcare facilities.
    Participants: 'Neonates' (<28 days of age) at risk of developing either clinical and/or laboratory-dependent diagnosis of sepsis.
    Outcome measures: Identification of any risk factors for neonatal sepsis.
    Results: A total of 36 studies with 23 605 patients from secondary or tertiary level of care facilities in 10 countries were included. Six studies were rated as good quality, 8 as fair and 22 as poor. Four studies were omitted in the meta-analysis due to insufficient data. The significant risk factors were resuscitation (OR 2.70, 95% CI 1.36 to 5.35), low birth weight <1.5 kg (OR 3.37, 95% CI 1.59 to 7.13) and 1.5-2.5 kg (OR 1.36, 95% CI 1.01 to 1.83), low Apgar score at the first minute (OR 3.69, 95% CI 2.34 to 5.81) and fifth minute (OR 2.55, 95% CI 1.46 to 4.45), prematurity <37 weeks (OR 1.91, 95% CI 1.27 to 2.86), no crying at birth (OR 3.49, 95% CI 1.42 to 8.55), male sex (OR 1.30, 95% CI 1.01 to 1.67), prolonged labour (OR 1.57, 95% CI 1.08 to 2.27), premature rupture of membranes (OR 2.15, 95% CI 1.34 to 3.47), multiple digital vaginal examinations (OR 2.22, 95% CI 1.27 to 3.89), meconium-stained amniotic fluid (OR 2.72, 95% CI 1.58 to 4.69), intrapartum maternal fever (OR 2.28, 95% CI 1.18 to 4.39), foul-smelling vaginal discharge (OR 3.31, 95% CI 2.16 to 5.09) and low socioeconomic status (OR 1.93, 95% CI 1.11 to 3.35). We found considerable heterogeneity in the meta-analysis of 11 out of 15 identified risk factors.
    Conclusion: Multiple risk factors for neonatal sepsis in Sub-Saharan Africa were identified. We revealed risk factors not listed by the WHO guidelines. The included studies overall had high risk of bias and high heterogeneity and thus, additional research of high quality is needed.
    Prospero registration number: CRD42020191067.
    MeSH term(s) Female ; Humans ; Infant, Low Birth Weight ; Infant, Newborn ; Infant, Newborn, Diseases ; Male ; Neonatal Sepsis/complications ; Neonatal Sepsis/epidemiology ; Risk Factors ; Sepsis/epidemiology ; Sepsis/etiology
    Language English
    Publishing date 2022-09-01
    Publishing country England
    Document type Journal Article ; Meta-Analysis ; Systematic Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2021-054491
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort.

    Stoltze, Ulrik Kristoffer / Hildonen, Mathis / Hansen, Thomas Van Overeem / Foss-Skiftesvik, Jon / Byrjalsen, Anna / Lundsgaard, Malene / Pignata, Laura / Grønskov, Karen / Tumer, Zeynep / Schmiegelow, Kjeld / Brok, Jesper Sune / Wadt, Karin A W

    Journal of medical genetics

    2023  Volume 60, Issue 9, Page(s) 842–849

    Abstract: Background: Studies suggest that Wilms tumours (WT) are caused by underlying genetic (5%-10%) and epigenetic (2%-29%) mechanisms, yet studies covering both aspects are sparse.: Methods: We performed prospective whole-genome sequencing of germline DNA ...

    Abstract Background: Studies suggest that Wilms tumours (WT) are caused by underlying genetic (5%-10%) and epigenetic (2%-29%) mechanisms, yet studies covering both aspects are sparse.
    Methods: We performed prospective whole-genome sequencing of germline DNA in Danish children diagnosed with WT from 2016 to 2021, and linked genotypes to deep phenotypes.
    Results: Of 24 patients (58% female), 3 (13%, all female) harboured pathogenic germline variants in WT risk genes (
    Conclusion: We find that most females (57%) and 33% of all patients with WT had either a genetic or another indicator of WT predisposition. This emphasises the need for scrutiny when diagnosing patients with WT, as early detection of underlying predisposition may impact treatment, follow-up and genetic counselling.
    MeSH term(s) Male ; Female ; Humans ; F-Box-WD Repeat-Containing Protein 7/genetics ; Fetal Macrosomia/genetics ; Genomic Imprinting ; Wilms Tumor/genetics ; Genotype ; Beckwith-Wiedemann Syndrome/pathology ; DNA Methylation/genetics ; Disease Susceptibility ; Kidney Neoplasms/genetics ; Germ Cells/pathology
    Chemical Substances F-Box-WD Repeat-Containing Protein 7
    Language English
    Publishing date 2023-04-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 220881-7
    ISSN 1468-6244 ; 0022-2593
    ISSN (online) 1468-6244
    ISSN 0022-2593
    DOI 10.1136/jmg-2022-108982
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Advances in the clinical management of high-risk Wilms tumors.

    Ortiz, Michael V / Koenig, Christa / Armstrong, Amy E / Brok, Jesper / de Camargo, Beatriz / Mavinkurve-Groothuis, Annelies M C / Herrera, Thelma B Velasquez / Venkatramani, Rajkumar / Woods, Andrew D / Dome, Jeffrey S / Spreafico, Filippo

    Pediatric blood & cancer

    2023  Volume 70, Issue 3, Page(s) e30153

    Abstract: Outcomes are excellent for the majority of patients with Wilms tumors (WT). However, there remain WT subgroups for which the survival rate is approximately 50% or lower. Acknowledging that the composition of this high-risk group has changed over time ... ...

    Abstract Outcomes are excellent for the majority of patients with Wilms tumors (WT). However, there remain WT subgroups for which the survival rate is approximately 50% or lower. Acknowledging that the composition of this high-risk group has changed over time reflecting improvements in therapy, we introduce the authors' view of the historical and current approach to the classification and treatment of high-risk WT. For this review, we consider high-risk WT to include patients with newly diagnosed metastatic blastemal-type or diffuse anaplastic histology, those who relapse after having been initially treated with three or more different chemotherapeutics, or those who relapse more than once. In certain low- or low middle-income settings, socio-economic factors expand the definition of what constitutes a high-risk WT. As conventional therapies are inadequate to cure the majority of high-risk WT patients, advancement of laboratory and early-phase clinical investigations to identify active agents is urgently needed.
    MeSH term(s) Humans ; Kidney Neoplasms/pathology ; Neoplasm Staging ; Wilms Tumor/pathology ; Prognosis ; Recurrence
    Language English
    Publishing date 2023-01-10
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.30153
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Advances in the clinical management of high-risk Wilms tumors.

    Ortiz, Michael V / Koenig, Christa / Armstrong, Amy E / Brok, Jesper / de Camargo, Beatriz / Mavinkurve-Groothuis, Annelies M C / Herrera, Thelma B Velasquez / Venkatramani, Rajkumar / Woods, Andrew D / Dome, Jeffrey S / Spreafico, Filippo

    Pediatric blood & cancer

    2023  Volume 70 Suppl 2, Page(s) e30342

    Abstract: Outcomes are excellent for the majority of patients with Wilms tumors (WT). However, there remain WT subgroups for which the survival rate is approximately 50% or lower. Acknowledging that the composition of this high-risk group has changed over time ... ...

    Abstract Outcomes are excellent for the majority of patients with Wilms tumors (WT). However, there remain WT subgroups for which the survival rate is approximately 50% or lower. Acknowledging that the composition of this high-risk group has changed over time reflecting improvements in therapy, we introduce the authors' view of the historical and current approach to the classification and treatment of high-risk WT. For this review, we consider high-risk WT to include patients with newly diagnosed metastatic blastemal-type or diffuse anaplastic histology, those who relapse after having been initially treated with three or more different chemotherapeutics, or those who relapse more than once. In certain low- or low middle-income settings, socio-economic factors expand the definition of what constitutes a high-risk WT. As conventional therapies are inadequate to cure the majority of high-risk WT patients, advancement of laboratory and early-phase clinical investigations to identify active agents is urgently needed.
    MeSH term(s) Humans ; Kidney Neoplasms/pathology ; Neoplasm Staging ; Wilms Tumor/pathology ; Prognosis ; Recurrence
    Language English
    Publishing date 2023-04-25
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.30342
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Home-Based Specialized Pediatric Palliative Care: A Systematic Review and Meta-Analysis.

    Hammer, Nanna Maria / Bidstrup, Pernille Envold / Brok, Jesper / Devantier, Minna / Sjøgren, Per / Schmiegelow, Kjeld / Larsen, Anders / Kurita, Geana Paula / Olsen, Marianne / Larsen, Hanne Bækgaard

    Journal of pain and symptom management

    2023  Volume 65, Issue 4, Page(s) e353–e368

    Abstract: Context: Although specialized pediatric palliative care (SPPC) teams increasingly provide home-based care, the evidence of its impact has not yet been systematically evaluated.: Objectives: To examine the impact of home-based SPPC in children and ... ...

    Abstract Context: Although specialized pediatric palliative care (SPPC) teams increasingly provide home-based care, the evidence of its impact has not yet been systematically evaluated.
    Objectives: To examine the impact of home-based SPPC in children and adolescents with life-limiting conditions, regarding place of death, quality of life and symptom burden.
    Methods: We searched Medline, EMBASE, CINAHL, PsycINFO, the Cochrane Central Register of Controlled Trials, Web of Science and Scopus for studies comparing children and adolescents with life-limiting conditions receiving home-based SPPC with children and adolescents not receiving home-based SPPC, or studies reporting before-and-after measurements. We included studies that reported on place of death, quality of life and/or symptoms. Two authors independently screened the articles, extracted data, and assessed quality. Results were synthesized as a systematic narrative synthesis and meta-analysis, using a random-effects model.
    Results: We included five studies, which reported on 392 children and adolescents. Meta-analysis showed that receiving home-based SPPC was associated with a more than fourfold increased likelihood of home death (risk ratio 4.64, 95% confidence interval 3.06-7.04; 3 studies; n=296). Most studies reported improved quality of life and reduced symptom burden. The included studies were of low to moderate quality with a high risk of bias.
    Conclusion: This systematic review suggests that home-based SPPC is associated with increased likelihood of home death, and might be associated with improved quality of life and reduced symptom burden. The small number of studies and an overall high risk of bias, however, makes the overall strength of evidence low.
    MeSH term(s) Adolescent ; Child ; Humans ; Palliative Care ; Quality of Life ; Hospice and Palliative Care Nursing ; Home Care Services
    Language English
    Publishing date 2023-01-06
    Publishing country United States
    Document type Meta-Analysis ; Systematic Review ; Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 639142-4
    ISSN 1873-6513 ; 0885-3924
    ISSN (online) 1873-6513
    ISSN 0885-3924
    DOI 10.1016/j.jpainsymman.2022.12.139
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top